Nivolumab monotherapy in metastatic urothelial cancer (mUC): updated efficacy by subgroups and safety results from the CheckMate 032 study - Rosenberg, Jonathan E.; Jäger, Dirk (Annals of oncology, 2016)
Gesehen am 10.11.2017